feedback

Course Director

Perry Mark Elliott, MBBS, MD, FRCP
Perry Mark Elliott, MBBS, MD, FRCP

University College London
and St. Bartholomew's Hospital
London, United Kingdom

Faculty

Aleš Linhart
Aleš Linhart, MD

General University Hospital
Prague, Czech Republic

Frank Weidemann
Frank Weidemann, MD

Katharinen-Hospital Unna
Unna, Germany

Accredited by

Oakstone Publishing, LLC

Activity Details

Credit Types:CME
Credit Amount:0.75 Credits
Release Date:2016-Oct-04
Expiration Date:2017-Oct-03
Estimated Time for Completion:45 minutes
Registration Required:No
Cost:Free of Charge

Funding Disclosure

This activity is supported by an educational grant from Shire.

Activity Description & Educational Objectives

In this activity, experts in Fabry disease discuss how cardiologists can recognise, diagnose, and treat patients with Fabry disease, an uncommon but potentially treatable condition.

Upon completion of this activity, participants should be better able to:

  • Describe the cardiovascular symptoms of Fabry disease and their impact on patient outcomes
  • Illustrate which cardiovascular investigations should be implemented for the differential diagnosis of Fabry disease
  • Explain how to confirm a diagnosis of Fabry disease and how to counsel patients thereafter
  • Identify the current treatment options for Fabry disease and their effect on CV disease and other symptoms

Target Audience

This activity has been designed to meet the educational needs of cardiologists and other clinicians involved in the diagnosis and treatment of Fabry disease.

Faculty & Disclosure / Conflict of Interest Policy

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, medical reviewers, and editorial staff disclose no relevant financial relationships with commercial interests.

Course Director and Interviewee

Perry Mark Elliott, MBBS, MD, FRCP
Professor of Cardiovascular Medicine
and Clinical Lead for Inherited
Cardiovascular Disease
University College London
and St Bartholomew’s Hospital
London, United Kingdom

Perry Mark Elliott, MBBS, MD, FRCP, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Genzyme (unrestricted educational grant).
Honoraria from Genzyme; Gilead; Pfizer; and Shire.
Advisory Board for Amicus; Genzyme; and Shire.

Aleš Linhart, MD
Head, Department of Internal-Cardiovascular Medicine
General University Hospital
First Medical Faculty
Charles University
Prague, Czech Republic

Aleš Linhart, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Amicus Therapeutics; Sanofi Genzyme; and Shire HGT.
Grant/Research Support from Shire HGT.
Speakers Bureau participant with Sanofi Genzyme and Shire HGT.
Honoraria from Amicus Therapeutics; Sanofi Genzyme; and Shire HGT.
Advisory Board for Amicus Therapeutics and Sanofi Genzyme.

Frank Weidemann, MD
Professor and Chief of Cardiology
Innere Klinik II, Katharinen-Hospital Unna
Unna, Germany

Frank Weidemann, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Sanofi Genzyme.
Grant/Research Support from Amicus; Sanofi Genzyme; and Shire.
Honoraria from Amicus; Sanofi Genzyme; and Shire.
Advisory Board for Sanofi Genzyme Registry.

Medical Director

Sonia Schursky
Sonia Schursky has no financial interests/relationships or affiliations in relation to this activity.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labelled for use in certain jurisdictions. Faculty members have been advised to disclose to the audience any reference to an unlabelled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our materials. No responsibility is taken for errors or omissions in our materials.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and PeerVoice. Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

Requirements for Successful Completion

To receive credit, participants must complete the online activity, the post-test, and the evaluation form prior to the expiration date noted below. There are no pre-requisites and there is no fee to participate in this activity or to receive credit. Certificates of Completion are awarded upon successful completion of the post-test and evaluation form. Consult your professional licencing board for information about your eligibility to claim credit for participation in this educational activity.

Media: Internet
Release and Expiration Dates: October 4, 2016 - October 3, 2017
Time to Complete: 45 minutes

About This PeerCME Activity

PeerVoice and Oakstone Publishing, LLC, are responsible for the selection of this activity's topics, the preparation of educational content, and the distribution of this activity. The preparation of PeerCME activities is supported by written agreements that clearly stipulate and enforce the independence of PeerVoice, Oakstone Publishing, LLC, and the faculty presenters.

The faculty may discuss unapproved products or uses of these products in certain jurisdictions. Faculty presenters have been advised to disclose any reference to an unlabelled or unapproved use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our activities. No responsibility is taken for errors or omissions.

For approved prescribing information, please consult the manufacturer's product monograph.

Copyright © 2012-2016, PeerCME

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.